Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P20.14.A METASTATIC EPITHELIOD SOLITARY FIBROUS TUMOR

View through CrossRef
Abstract BACKGROUND Epitheliod solitary fibrous tumor is a rare central nervous system tumor that can rarely metastasize. An unusual case is illustrated. MATERIAL AND METHODS A 76 year old man underwent resection of a lower cervical spinal cord (C5-C7) tumor that was called hemangiopericytoma at time of resection. He was treated with radiotherapy. Twenty-four years later he presented with headache and gait ataxia and neuroimaging revealed a 4th ventricular tumor. He underwent surgical resection via a suboccipital craniectomy. RESULTS Pathology showed a hypercellular tumor composed of epitheliod cells with eosinophilic cytoplasm and moderately pleomorphic enlarged oval nuclei containing finely dispersed chromatin and prominent eosinophilic nucleoli in some nuclei. The tumor cells were arranged in nests and sheets separated by thin walled branching to thick walled hyalinized vessels with frequent areas of hemorrhage. Tumor cells showed high mitotic activity (about 8 mitoses/mm squared). The majority of tumor cells were positive for CK7, synaptophysin, E-cadherin, and rarely for CK20 and D2-40. Tumor cells were negative for EMA, transthyretin, myogenin, desmin, progesterone receptor, NeuN, Olig-2, TTF-1, GATA3, PAX8, OCT3/4, SALL4, CD117, S100 and GFAP. Vasculature was highlighted by PAS, reticulin, CD31, ERG, and CD34. INI-1 was intact in the nuclei. Final diagnosis was epitheliod solitary fibrous tumor, at least CNS WHO grade 2. This was consistent with the pathology from 24 years prior. CONCLUSION Solitary fibrous tumor is known for recurrence and metastasis a long time after initial diagnosis. However, this case highlights the delayed metastatic spread of a relatively rare subtype of solitary fibrous tumor (epitheliod) to a rare location (intraventricular, specifically the 4th ventricle). The literature will be reviewed.
Title: P20.14.A METASTATIC EPITHELIOD SOLITARY FIBROUS TUMOR
Description:
Abstract BACKGROUND Epitheliod solitary fibrous tumor is a rare central nervous system tumor that can rarely metastasize.
An unusual case is illustrated.
MATERIAL AND METHODS A 76 year old man underwent resection of a lower cervical spinal cord (C5-C7) tumor that was called hemangiopericytoma at time of resection.
He was treated with radiotherapy.
Twenty-four years later he presented with headache and gait ataxia and neuroimaging revealed a 4th ventricular tumor.
He underwent surgical resection via a suboccipital craniectomy.
RESULTS Pathology showed a hypercellular tumor composed of epitheliod cells with eosinophilic cytoplasm and moderately pleomorphic enlarged oval nuclei containing finely dispersed chromatin and prominent eosinophilic nucleoli in some nuclei.
The tumor cells were arranged in nests and sheets separated by thin walled branching to thick walled hyalinized vessels with frequent areas of hemorrhage.
Tumor cells showed high mitotic activity (about 8 mitoses/mm squared).
The majority of tumor cells were positive for CK7, synaptophysin, E-cadherin, and rarely for CK20 and D2-40.
Tumor cells were negative for EMA, transthyretin, myogenin, desmin, progesterone receptor, NeuN, Olig-2, TTF-1, GATA3, PAX8, OCT3/4, SALL4, CD117, S100 and GFAP.
Vasculature was highlighted by PAS, reticulin, CD31, ERG, and CD34.
INI-1 was intact in the nuclei.
Final diagnosis was epitheliod solitary fibrous tumor, at least CNS WHO grade 2.
This was consistent with the pathology from 24 years prior.
CONCLUSION Solitary fibrous tumor is known for recurrence and metastasis a long time after initial diagnosis.
However, this case highlights the delayed metastatic spread of a relatively rare subtype of solitary fibrous tumor (epitheliod) to a rare location (intraventricular, specifically the 4th ventricle).
The literature will be reviewed.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Unusual Metastasis from Follicular Thyroid Carcinoma: A Case Report and Literature Review
Unusual Metastasis from Follicular Thyroid Carcinoma: A Case Report and Literature Review
Abstract Introduction Follicular thyroid carcinoma (FTC) is a type of well-differentiated thyroid carcinoma. It has a poorer prognosis, is more metastatic, and has characteristics ...
YAP1 and downstream gene alterations in metastatic breast cancer.
YAP1 and downstream gene alterations in metastatic breast cancer.
e13121 Background: Metastatic breast cancer remains a major clinical challenge, characterized by poor prognosis and limited therapeuti...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract Introduction Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Abstract 5897: Tumor-derived bacteria drive breast cancer metastasis
Abstract 5897: Tumor-derived bacteria drive breast cancer metastasis
Abstract Metastasis is a major barrier to long-term survival and therapeutic options for aggressive, metastatic forms of breast cancer remain limited. Studies using ...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...

Back to Top